Our Research:
Our laboratory has three major areas of interest, each of which deals with some aspect of growth factor signaling and function in the retina and retinal pigmented epithelium (RPE).
- Investigations aimed at gaining a better understanding of the pathogenesis of retinal and choroidal neovascularization and developing new ways to treat them.
- Investigations aimed at understanding the molecular signals involved in retinal and RPE wound repair and scarring. The prototypical disease in this category is proliferative vitreoretinopathy and our lab is seeking to identify new treatments.
- Investigations aimed at understanding why retinal degenerations occur and how they might be treated, with particular emphasis on neurotrophic factors.
Director, Retinal Cell and Molecular Laboratory
Peter Anthony Campochiaro, M.D.
Research Interests:
Mechanisms involved in ocular neovascularization, Development of new treatments for ocular neovascularization, Mechanisms involved in retinal degenerations, Development of new treatments for retinal degenerations, Ocular Gene Therapy, Clinical trials of ocular neovascularization and macular edema
Lab Personnel
-
-
-
-
-
-
-
Dawn Lang, Administrative Assistant
phone: 410-955-5106
fax: 410-614-7083
Appointments: 410-955-3518
Contact Us
Office: Maumenee 719600 North Wolfe St.
Baltimore, MD 21287-9277
Laboratory: Maumenee 815
600 North Wolfe St.
Baltimore, MD 21287-9277
phone: 410-955-4103
fax: 410-614-7083